11/11
08:09 am
ikna
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Low
Report
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
11/9
10:11 am
ikna
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) [Yahoo! Finance]
Low
Report
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) [Yahoo! Finance]
11/7
08:30 am
ikna
Ikena Oncology Reports Third Quarter 2024 Financial Results
Low
Report
Ikena Oncology Reports Third Quarter 2024 Financial Results